Tag Archives: MC1986

JLINKEDIN: Merlino, Therese McCarthy [MC1986] Consultant in IT Mgmt

2019-Mar-11

https://www.linkedin.com/in/theresemerlino/

Merlino, Therese McCarthy [MC1986]
Independent Consultant
Information Technology Management

Results-oriented technology professional with an emphasis on project management; proven leadership experience through design, implementation, and support of large-scale systems initiatives of commercially available, open source, or custom developed software.

Project Management Professional with notable success directing a broad range of IT initiatives; experienced with a proven track record of successful leadership managing IT operations for manufacturing, pharmaceutical, hospital, healthcare, academic medical, and high-tech industries.

Demonstrated capacity to implement innovative solutions and adhere to “best practices” to streamline business processes or solve business problems.; create road-maps and manage business process change to achieve those goals.

Proven leadership abilities; able to coordinate and direct all phases of project-based efforts while managing, motivating, and leading project teams.

Adept at developing effective business process improvements, project documentation, developing risk management/quality plans, and technical/business specifications.

Manage global system implementations of ERP, HRIS, CRM, MRP, Project Management, Business Intelligence in addition to other business productivity systems for hosted and cloud computing environments.

Well versed in HIPAA, HITECH, SOX, FDA, CFR, GMP and PCI regulations.

Experienced in procurement of software, services including the development bid proposals (RFI, RFP, RFQ), conducting bid review meetings, and response analysis.

Specialties: Managed system implementations for ERP, CRM, MRP. Financial Systems, HR/Payroll Systems, eProcurement, Project Management, eCommerce, PCI Remediation, Time & Attendance.

Significant experience in the pharmaceutical industry including validation experience of GMP regulated systems including the development of IQ, OQ, and PQ protocols.

In-depth understanding of hospital accounting, healthcare revenue systems, project accounting; well versed in health care regulations and auditing practices.

# – # – # – # – # 2019-Mar-11 @ 15:27

Advertisements

JFOUND: McGrath, Michele [MC1986] Dir Global Eng Grp @ Air Products

2019-Feb-01

https://www.davincisciencecenter.org/news/2019-wise-forum/

2019 WISE Forum Brings Female Perspectives to STEM Fields

*** begin quote ***

The Da Vinci Science Center will host a free panel discussion on Tuesday, Feb. 12, at DeSales University, Center Valley, Pa., as part of the 2019 Women in Science and Engineering (WISE) Forum presented by Sanofi Pasteur.  Distinguished female leaders in science, technology, engineering, and math (STEM) will discuss different perspectives women bring to these industries and challenges they face when pursuing a career in male-dominated fields.  

The public is invited to attend the free panel discussion scheduled to start at 7:30 p.m. in the Main Dining Room of University Center.  After opening remarks, panelists will each offer comments before inviting the audience members to ask questions.  Doors to the venue will open at 7 p.m.; Parking is available in the lot in front of the building. 

For more information, contact Sharon Alexander, CFRE, Campaign Manager, 484-664-1002, Ext. 125.

*** and ***

Michele McGrath

Michele McGrath is currently a Director in the Global Engineering and Manufacturing Group at Air Products.  After graduating from Manhattan College in 1986 with a degree in chemical engineering, she joined Air Products as a participant in the Career Development Program. She began her career as a project engineer where she managed the engineering, construction, and start up of Air Separation facilities in North America, Mexico and Indonesia. 

Michele later moved to operations where she held various roles over 20 years including, Line Management for Plant Operations and Distribution, Operations Manager, Mexico and Latin America, and Director of Global Plant Process Engineering.   In her most recent operations role she was responsible for supporting the resolution of process technical issues at operating facilities and improving the productivity of assets in the areas of process efficiency and advanced controls and operability.

*** end quote ***

McGrath, Michele [MC1986]

# – # – # – # – # 2019-Feb-01 @ 09:05

JFOUND: Fossaceca, John M. [MC1986] “Transforming DoD IT”

2018-Dec-30

http://smallwarsjournal.com/author/john-m-fossaceca

Transforming DoD Information Technology Through Coalition Partner Trust
Sun, 12/30/2018 – 8:09am
Small Wars Journal
John M. Fossaceca

BIO

John M. Fossaceca, PhD, is currently a research scientist with the U.S. Army Research Lab’s Information Sciences Division. Earlier in his career, Dr. Fossaceca was VP of Engineering, Product management and Technology at 3e Technologies International (3eTI), a division of Ultra Electronics, serving as the Principal Investigator on several US government Small Business Innovative Research (SBIR) programs and was instrumental in creating secure wireless systems for the U.S. Navy.  As Engineering Vice President and COO at Comtech Mobile Datacom he led modernization efforts for the U.S. Army’s Blue Force Tracking command and control satellite-based tracking system.  Dr. Fossaceca previously served as Technical Director for AT&T/Lucent Technologies in Holmdel and Murray Hill, NJ contributing to wireless telephony products and next-generation VoIP and packet-based communication systems. He has published recent research in machine learning for network intrusion detection and is co-inventor on six patents related to wireless communications, and adaptive signal detection. Dr. Fossaceca holds a Bachelor’s degree in Electrical Engineering from Manhattan College, a Master’s degree in Electrical Engineering from Syracuse University, an MBA from Virginia Tech and a Ph.D. in Systems Engineering from George Washington University.

# – # – #

Fossaceca, John M. [MC????]

# – # – # – # – # 2018-Dec-30 @ 21:39

Dear John,

I believe that John is a member of the Class of 1986.

Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

Fossaceca, John M. [MC1986]

# – # – # – # – # 2018-Dec-30 @ 23:50

JNEWS: Stromberg, Pierre [MC1986] looks for proof of a visit by alien

2018-Dec-02

https://www.seattletimes.com/seattle-news/proof-of-alien-visitors-artifact-from-an-ancient-civilization-the-truth-is-out-there-in-seattle/

Local News
Proof of alien visitors? Artifact from an ancient civilization? The truth is out there — in Seattle
Originally published December 1, 2018 at 6:00 am
By Erik Lacitis Seattle Times staff reporter

*** begin quote *** 

For years, the strange object embedded in a rocklike formation sparked speculation and wonder. Was it proof of a visit by aliens? It’s at the Pacific Science Center for you to see for yourself. The truth is out there.

For 57 years, since its discovery by three rockhounds in the mountains of Eastern California, an oblong, 2- by 3-inch stonelike mass has been at the heart of speculation around the world.

Oh, how we want to believe that the truth is out there.

*** and ***

Stromberg, 54, a 1986 graduate in computer science from Manhattan College in the Bronx, where he grew up, says that as a kid he read Erich von Daniken’s “Chariots of the Gods?”, which theorizes extraterrestrials influenced early human life. Pretty neat stuff, he thought back then.

*** end quote ***

Stromberg, Pierre [MC1986]

JNEWS: Butler, John P. [MC1986] BoD Zynerba Pharma

2018-Apr-16

https://globenewswire.com/news-release/2018/04/16/1471865/0/en/Zynerba-Pharmaceuticals-Appoints-John-P-Butler-to-Board-of-Directors.html

Zynerba Pharmaceuticals Appoints John P. Butler to Board of Directors
April 16, 2018 07:00 ET | Source: Zynerba Pharmaceuticals, Inc.

DEVON, Pa., April 16, 2018 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty neuropsychiatric pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments for rare and near-rare neurological and psychiatric disorders with high unmet medical needs, today announced the appointment of John Butler to its board of directors. Mr. Butler serves as the President, Chief Executive Officer and member of the Board of Directors at Akebia Therapeutics.

“We are excited to welcome John to our Board at such an important time in our evolution,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “John is a recognized leader in our industry, and his extensive operational and commercialization experience in rare diseases will be instrumental as we execute on our vision to bring new therapeutic options to patients with rare and debilitating neuropsychiatric disorders.”

Mr. Butler has served as the President, Chief Executive Officer and member of the Board of Directors of Akebia Therapeutics, Inc. since 2013, where he has led the company through its IPO and multiple strategic partnering transactions. Previously Mr. Butler served as the Chief Executive Officer of Inspiration Biopharmaceuticals, Inc. where he led the transactions that resulted in the sale of Inspiration’s hemophilia assets to Cangene Corporation and Baxter International for a total aggregate consideration that could exceed one billion dollars. From 1997 to 2011, Mr. Butler held various positions of increasing strategic importance at Genzyme Corporation, culminating in his tenure as President of the company’s rare genetic diseases business. Prior to his work at Genzyme, Mr. Butler held sales and marketing positions at Amgen and Hoffmann-La Roche. He was a member of the Board of Directors of Relypsa, Inc. from 2013 to 2016, and Chairman of the Board at Keryx Biopharmaceuticals, from 2015 to 2017. Mr. Butler received a B.A. in Chemistry from Manhattan College and an M.B.A. degree from Baruch College, City University of New York.

“This is an important and exciting time for Zynerba as they initiate a pivotal program in Fragile X syndrome mid-year and begin their transition into a commercial stage company,” said Mr. Butler. “I look forward to contributing to the Company’s success as they work to change the lives of people living with certain rare and near-rare neuropsychiatric diseases and their families.”

# – # – #

Butler, John P. [MC????]  

# – # – # – # – #

Dear John,

I believe that John is a member of the Class of 1986.

Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

Butler, John P. [MC1986]

# – # – # – # – # 2018-Apr-16 @ 21:49

JLINKEDIN: Daly, Mary Hewitt [MC1986] Air Quality & Enviro Consultant

2018-Feb-18

https://www.linkedin.com/in/maryhdaly/

Daly, Mary Hewitt [MC1986]
Independent Air Quality & Environmental Consultant
Surrey Environmental Consulting, LLC

A dedicated air quality engineer/project manager with over 30 years of experience in air quality regulatory compliance, permitting and negotiation with various regulatory agencies in multiple states across the U.S. Provides services for industrial, municipal, and federal clients for a multitude of sectors.

Specialties: Air Quality Regulatory Permitting, Compliance Evaluations/Strategies, Negotiations, Technology Assessments, Emission Inventories, Facility Wide Audits, Stack Testing Oversight/Management.

# – # – # – # – # 2018-Feb-18 @ 09:59

JNEWS: Canavan, Ken [MC1986] CTO Westinghouse

2017-Nov-30

http://www.businesswire.com/news/home/20171130005555/en/Westinghouse-Appoints-Ken-Canavan-Chief-Technology-Officer

November 30, 2017 08:30 AM Eastern Standard Time

PITTSBURGH–(BUSINESS WIRE)–Westinghouse Electric Company announced today that Ken Canavan has been appointed chief technology officer (CTO), effective January 2, 2018.

“We are excited to have Ken join us, especially during this strategic transition point in Westinghouse’s history,” said José Emeterio Gutiérrez, president and chief executive officer, Westinghouse Electric Company. “Ken brings expertise and rigor that will further solidify the technology that is a hallmark of Westinghouse.”

Westinghouse’s CTO role has strategic responsibility to drive next-generation technology and innovation solutions that align with the company’s global business strategy. Canavan will lead these efforts, as well as strengthen Westinghouse with regard to technology leadership development.
Canavan, 53, previously was director of engineering for the Electric Power Research Institute (EPRI). There he was responsible for turning industry needs into compelling research and development plans. These plans improved safety and performance of the global nuclear fleet. He has more than 30 years of experience in key engineering and risk management roles. Prior to his work at EPRI, Canavan was responsible for risk applications at Data Systems and Solutions, ERIN Engineering and Research and GPU Nuclear. He also was a safety analysis engineer with Davis-Besse Nuclear Power Station in Ohio (USA).

Canavan has a bachelor’s degree in chemical engineering, with a nuclear engineering minor, from Manhattan College, New York. Ken, his wife, Paula and his two children will relocate to the Pittsburgh area.

# – # – # – # – # 

Canavan, Ken [MC????]

# – # – # – # – #  2017-Nov-30 @ 13:27  

Dear John,

             I beleive that Ken is a member of the class of 1986.

                          Mike

McEneney, Mike (MC1953)

[JR: Thanks, Mike. Much appreciated.]

Canavan, Ken [MC1986]

# – # – # – # – # 2017-Nov-30 @ 15:16